Institutional investors purchased a net $130.4 million shares of ABBV during the quarter ended December 2014 and now own 72.23% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 1.9 Million shares of AbbVie
INVERNESS COUNSEL LLC Bought 316.0 Thousand shares of AbbVie
STATE STREET GLOBAL ADVISORS LTD... Bought 175.3 Thousand shares of AbbVie